Close 2026-08-21 1267 scanned A

KPL

Kwality Pharmaceuticals
Small capRs 3,488 crRs 10.3 cr traded a day
Close on 2026-08-21
3,361.10
−7.42%
52-week range90% of the way up
838.203,630.30
Market cap
3,488 cr
P/E (TTM)
43.0×
EPS (TTM)
78.11
Revenue YoY
+45.6%
Q1 FY27
Profit YoY
+115.0%
Net margin
15.8%
+5.1pt vs a year ago
Growth trend
+9.8pt
vs last quarter’s YoY
1 month
+25.8%
Below 52w high
8.0%
RSI (14)
73
overbought
Daily swing
6.8%
average true range
Volume
1.4×
vs 20-day average
Traded
Rs 10 cr
median day
Close200-day averageMaterial filing
1,0002,0003,000Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26
260 sessions · hover for the filing behind a move
1 week
−2.19%
1 month
+25.78%
3 months
+55.32%
6 months
+131.22%
1 year
+236.09%

The read

written from the numbers on this page
The evidence leans constructive8 supporting, 0 against, 1 worth knowing

Supporting

  • trading 93% above its 200-day average
  • sitting at 90% of its 52-week range, with little overhead supply from trapped buyers
  • up 236% over twelve months
  • matches stretched far above trend, which has beaten the market by +0.82 points over 20 sessions across 27,715 past signals
  • 2 of the scans it matches have a positive measured record
  • 4 independent kinds of evidence agree today, which is uncommon
  • revenue grew 46% year on year in the quarter ending 2026-06-30
  • net margin has widened from 12.7% to 15.8% across four quarters

Against

  • nothing the data supports either way

Worth knowing

  • RSI at 73 is stretched; strong stocks stay stretched for a long time, so this is a note on entry timing, not on direction
What would change this read: a close below 1,740, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.

How it has performed

price return over each window, measured against zero
-2.2%1W+25.8%1M+55.3%3M+131.2%6M+236.1%1Y

What the scans say today

10 of 47 matched on 2026-08-21
KPL matches 10 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.

Valuation against its own history

132 sessions since 2026-02-12
26×
median 33×
43×
now 43×
KPL trades at 43× trailing earnings, above its median of 33× over this window — 29% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.

Recent filings

from the exchange, newest first
Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352)

The business

from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
11611111112315716212.5%10.7%12.7%13.0%16.1%15.8%Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.

Going for it

  • revenue grew 46% against the same quarter a year earlier
  • profit rose 115% year on year
  • revenue rose in 3 of the last 4 quarters

Going against it

  • net margin narrowed from 16.1% to 15.8%
Quarter-by-quarter numbers, as filed
QuarterRevenueProfit before taxNet profitEPSNet margin
Q1 FY27
2026-06-30 · consolidated
162342624.6915.8%
Q4 FY26
2026-03-31 · consolidated
157322524.3916.1%
Q3 FY26
2025-12-31 · consolidated
123221615.4213.0%
Q2 FY26
2025-09-30 · consolidated
111181413.6012.7%
Q1 FY26
2025-06-30 · consolidated
111171211.4910.7%
Q4 FY25
2025-03-31 · consolidated
116191413.9512.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.

Where the price stands

the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+21.8%
Versus 200-day average+93.1%
Below 52-week high-7.4%
Above 52-week low+301.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)72.6
Higher closes in last 52 of 5
Six-month return+131.22%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)6.81%
Volume versus 20-day1.4x
Median daily turnoverRs 10.3 cr

Recent sessions

what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
SessionScansWhich
2026-08-201Above the 200-day EMA